The global recombinant DNA technology market is driven by increased applications in the treatment of fatal human diseases such as infectious diseases. The advancement in recombinant technology has led to the development of gene therapy, long-acting therapeutic proteins for drugs, and cutting-edge molecular medicine. The ongoing technological development coupled with these therapies' effective results further propagates strong growth waves in the market. Such growth momentum is expected to continue with the growing number of initiatives taken by both government and private organizations for the adoption of recombinant DNA technology. Another major driver is the advancement of treatment methods due to the introduction of novel products including diagnostic tools, monitoring systems, and novel therapy techniques. All these trends together are projected to create inroads into the global recombinant DNA technology market.

For More Industry Insight Read:

https://www.fairfieldmarketresearch.com/report/recombinant-dna-technology-market

Rising Technological Advancements Due to Increased R&D Initiatives Aids Market Expansion

The increased R&D activities for treating serious illnesses such as immunodeficiency disorders, cancers, and diabetes, are driving the recombinant DNA technology market growth. The confluence of recombinant DNA technology and medication enables the replacement of faulty genes in a patient’s body with healthy ones. In addition to this, gene therapy, made possible due to improvement in recombinant technology, can cure hereditary illnesses. Moreover, recombinant DNA technology has also improved the development of DNA technology as researchers can now create human insulin using bacteria as the host cell. This drug has proven to be more effective than standard medications as microbes produce it.

Rising Production of Genetically Modified Crops Creates Significant Growth Prospects

The global recombinant DNA technology market is expanded over a wide range of applications including therapeutics, agriculture, and research. During the study period, the market is likely to receive a major boost from the agriculture sector. This is mainly attributed to the rising demand for genetically modified crops in the agriculture industry to boost yield and increase resistance to herbicides or pesticides. Moreover, key market players are forging strategic alliances with leading academic institutions to develop breakthrough products. Against this backdrop, the market is projected to undergo robust expansion over the forecasted period.

North America to Forge Ahead as a Key Area with Presence of Numerous Biopharmaceutical Manufacturing Businesses

North America is projected to emerge as a key region in the global recombinant DNA technology market. The U.S. holds a lion’s share in the regional market due to the widespread presence of biopharmaceutical manufacturing firms. In addition to this, the establishment of regulatory institutions to ensure the ethical use of technology is enabling the swift expansion of the regional market. Meanwhile, Europe’s recombinant DNA technology market is expected to grow at the highest rate throughout the projected period. The increased government investment in the healthcare industry is accelerating regional market growth.

Prominent Market Players

Some of the major players in the recombinant DNA technology industry include Biogen, Inc., Sanofi Pasteur, Merck & Co., Inc., Thermo Fisher Scientific, Inc., Profacgen, Amgen, Inc., Pfizer, Inc., and Monsanto Company.

Get Sample/Toc Copy Of Report:

https://www.fairfieldmarketresearch.com/report/recombinant-dna-technology-market/request-toc

Latest Trending Reports:

About Us

Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure customers’ ever-changing needs are met with absolute promptness. 

Contact 

Fairfield Market Research  

London, UK 

UK +44 (0)20 30025888     

USA (Toll-free) +1 (844) 3829746  

Web: https://www.fairfieldmarketresearch.com/  

Email: sales@fairfieldmarketresearch.com 

Follow Us: LinkedIn